Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma
Inducible genetically defined mouse models of cancer uniquely facilitate the investigation of early events in cancer progression, however, there are valid concerns about the ability of such models to faithfully recapitulate human disease. We developed an inducible mouse model of progressive lung ade...
Main Authors: | Sarah Neidler, Björn Kruspig, Kay Hewit, Tiziana Monteverde, Katarina Gyuraszova, Attila Braun, William Clark, Daniel James, Ann Hedley, Bernhard Nieswandt, Emma Shanks, Craig Dick, Daniel J. Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/600 |
Similar Items
-
The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
by: Zheng DF, et al.
Published: (2016-02-01) -
Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
by: Albert Grinshpun, et al.
Published: (2019-01-01) -
Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure
by: Tyler M. Bauer, et al.
Published: (2018-11-01) -
WT1 Enhances Proliferation and Impedes Apoptosis in KRAS Mutant NSCLC via Targeting cMyc
by: Chen Wu, et al.
Published: (2015-01-01) -
The low prevalence of colonic serrated adenocarcinoma with high KRAS mutational status at Cipto Mangunkusumo Hospital, Indonesia
by: Nur Rahadiani, et al.
Published: (2018-10-01)